RADLY (Raia Drogasil) Cyclically Adjusted Revenue per Share: $3.67 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RADLY Raia Drogasil SA RADLY
91 GF Score
Price $3.77
GF Value $6.04
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Raia Drogasil Cyclically Adjusted Revenue per Share?

Raia Drogasil RADLY +3.29% 91 Cyclically Adjusted Revenue per Share is $3.67 as of Mar. 2026. GuruFocus rates RADLY with a GF Score™ of 91/100 and a GF Value™ of $6.04 (Significantly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Raia Drogasil's adjusted revenue per share for the three months ended in Mar. 2026 was $1.194. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $3.67 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Raia Drogasil's average Cyclically Adjusted Revenue Growth Rate was 8.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 13.70% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 16.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Raia Drogasil was 18.90% per year. The lowest was 13.60% per year. And the median was 17.60% per year.

As of today (2026-08-05), Raia Drogasil's current stock price is $3.77. Raia Drogasil's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was $3.67. Raia Drogasil's Cyclically Adjusted PS Ratio of today is 1.03.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Raia Drogasil was 3.18. The lowest was 0.75. And the median was 2.00.


Raia Drogasil  (OTCPK:RADLY) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Raia Drogasil's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=3.77/3.67
=1.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Raia Drogasil was 3.18. The lowest was 0.75. And the median was 2.00.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Raia Drogasil Cyclically Adjusted Revenue per Share Related Terms


Raia Drogasil Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Raia Drogasil's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Raia Drogasil Cyclically Adjusted Revenue per Share Chart

Raia Drogasil Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.98 2.41 3.53 2.48 3.57

Raia Drogasil Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.33 3.19 3.32 3.57 3.67

Raia Drogasil Cyclically Adjusted Revenue per Share Competitor Comparison

For the Pharmaceutical Retailers subindustry, Raia Drogasil's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Raia Drogasil Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raia Drogasil's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Raia Drogasil's Cyclically Adjusted PS Ratio falls into.


RADLY
91GF Score
Raia Drogasil SA RADLY
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Raia Drogasil Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Raia Drogasil's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.194/175.0655*175.0655
=1.194

Current CPI (Mar. 2026) = 175.0655.

Raia Drogasil Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.465 108.851 0.748
201609 0.510 109.986 0.812
201612 0.521 110.802 0.823
201703 1.117 111.869 1.748
201706 0.561 112.115 0.876
201709 1.246 112.777 1.934
201712 0.608 114.068 0.933
201803 0.599 114.868 0.913
201806 0.548 117.038 0.820
201809 0.523 117.881 0.777
201812 0.589 118.340 0.871
201903 0.589 120.124 0.858
201906 0.627 120.977 0.907
201909 0.639 121.292 0.922
201912 0.667 123.436 0.946
202003 0.580 124.092 0.818
202006 0.492 123.557 0.697
202009 0.537 125.095 0.752
202012 0.617 129.012 0.837
202103 0.565 131.660 0.751
202106 0.664 133.871 0.868
202109 0.665 137.913 0.844
202112 0.652 141.992 0.804
202203 0.746 146.537 0.891
202206 0.841 149.784 0.983
202209 0.846 147.800 1.002
202212 0.888 150.207 1.035
202303 0.887 153.352 1.013
202306 1.018 154.519 1.153
202309 1.020 155.464 1.149
202312 1.228 157.148 1.368
202403 1.074 159.372 1.180
202406 1.028 161.052 1.117
202409 1.066 162.342 1.150
202412 0.983 164.740 1.045
202503 0.954 168.102 0.994
202506 1.157 169.670 1.194
202509 1.240 170.739 1.271
202512 1.429 171.765 1.456
202603 1.194 175.066 1.194

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $3.67 mean?
Raia Drogasil (RADLY) has a Cyclically Adjusted Revenue per Share of $3.67 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Raia Drogasil and its competitors.
Is Raia Drogasil's Cyclically Adjusted Revenue per Share too high?
Raia Drogasil's current Cyclically Adjusted Revenue per Share is $3.67. Overall, Raia Drogasil has a GF Score™ of 91/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Raia Drogasil's Cyclically Adjusted Revenue per Share compare to competitors?
Raia Drogasil's Cyclically Adjusted Revenue per Share of $3.67 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Raia Drogasil and its competitors. Raia Drogasil's current Cyclically Adjusted Revenue per Share is $3.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raia Drogasil stock overvalued right now?
Based on GuruFocus' analysis, Raia Drogasil (RADLY) is currently considered Significantly Undervalued. The stock's GF Value™ is $6.04, compared to a current price of $3.77 — trading 37.6% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is $3.67. Raia Drogasil's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Raia Drogasil (RADLY), the current Cyclically Adjusted Revenue per Share is $3.67 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Raia Drogasil (RADLY) Overvalued in 2026?

Based on GuruFocus' analysis, Raia Drogasil stock appears to be undervalued. The current stock price of $3.77 is trading 37.6% below its estimated GF Value™ of $6.04. GuruFocus considers Raia Drogasil to be Significantly Undervalued.

Key valuation signals for RADLY:

  • Cyclically Adjusted Revenue per Share: $3.67
  • GF Value™: $6.04 vs. price of $3.77 (37.6% below fair value)
  • GF Score™: 91/100 with 3 warning signs

No single metric tells the full story. See the RADLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Raia Drogasil Business Description

Other Exchanges RADL3:Brazil
Address Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-900
Raia Drogasil SA operates a chain of pharmacies in Brazil. The company is mainly engaged in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines. Its pharmacies mainly operate under the Drogasil and Raia brands.
91GF Score

Get the complete analysis for RADLY

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.77
Price
$6.04
GF Value